50% off Premium Yearly

CVE:SVA
Billy Kawasaki’s Insights - Billy’s most-liked answers from 5i Research. The stock probably has some legs. The Type 1 diabetes treatment they are working on is getting lots of attention. Trials continue to show results and they have raised money and signed agreements with large companies. It is a new biotech play and the potential market is very large. Unlock Premium - Try 5i Free
Sernova Corp. is a Canadian stock, trading under the symbol SVA.V (previously SVA-X on Stockchase) on the TSX Venture Exchange (SVA-CV). It is usually referred to as TSXV:SVA or SVA.V
In the last year, no analyst issued a Buy, Sell, or Hold rating on SVA.V (previously SVA-X on Stockchase) on Stockchase. Read the latest expert commentary for Sernova Corp..
Sernova Corp. was never recommended as a Top Pick on Stockchase. Read the latest stock experts ratings for Sernova Corp..
Earnings reports or recent company news can cause the stock price to drop. Read stock experts' recommendations for Sernova Corp..
Sernova Corp. is followed by 57 investors on Stockchase and is a trending stock that is worth watching.
On 2022-06-01, Sernova Corp. (SVA.V) stock closed at a price of $1.57.